ClinicalTrials.gg
RecruitingNCT04229043Updated Nov 10, 2026

Gastric Emptying of Water and Sports Drink in Labor

An interventional study of Sports drink and Water in Pregnancy and Gastric Emptying, sponsored by Beth Israel Deaconess Medical Center. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Beth Israel Deaconess Medical Center · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Feb 2021; still recruiting 5 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

To determine the half time of the emptying of the stomach of women in early labor with and without epidural pain relief when drinking either water or a carbohydrate-based sports drink.

Read the detailed description

This is a randomized un-blinded study comparing the gastric emptying halftime of water versus a carbohydrate-based sports drink.

Cohorts Women in early labor who have not received pain medication will be enrolled in the study. This will be called the 'unmedicated' group. A second cohort of women who have received an epidural in early labor will be enrolled and studied using identical methods. This will be the 'epidural' group.

Study Intervention Subjects in each group will drink one of two drinks: water or sports drink. The changing volume in the stomach will be measured using ultrasound over the next 60 minutes. Subjects will be asked their degree of hunger on a 10-centimeter visual analogue scale prior to drinking, and for the next two hours at regular intervals. Subjects will be free to consume as per obstetric protocols. The study will be finished once the patient consumes food or drink, feels hunger ≥4/10, or two hours after the sports drink.

Hypothesis The primary hypothesis is that water will empty faster than the sports drink. A second hypothesis is that women with epidural pain relief will have similar gastric halftimes as women without pain medications.

02

Conditions studied

  • Pregnancy
  • Gastric Emptying
03

In context

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 570 studies on the registry; 80 are open to participants now.

Of its 76 completed or terminated interventional studies of FDA-regulated products, 62 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gestational age of 36 weeks or greater
  • American Society of Anesthesiology Physical Status 2 or 3
  • Induction of labor or early labor (cervical dilation \< 6cm)
  • Singleton gestation

Exclusion criteria

Exclusion Criteria:

  • Recent food ingestion (\<3 hours)
  • Preeclampsia
  • Receiving magnesium sulfate
  • Having received narcotics within 12 hours
  • Diabetes mellitus
  • Multiple gestations
  • Active nausea or reflux symptoms
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (estimated)

Study arms

  • Active comparator
    Early labor, no analgesia: Sports drink

    Subject will ingest 100 ml of a carbohydrate sports drink

    Dietary Supplement: Sports drink

  • Placebo comparator
    Early Labor, no analgesia: Water

    Subject will ingest 100 ml of water

    Dietary Supplement: Water

  • Active comparator
    Early labor, analgesia: Sports drink

    Subject will ingest 100 ml of a carbohydrate sports drink

    Dietary Supplement: Sports drink

  • Placebo comparator
    Early labor, analgesia: Water

    Subject will ingest 100 ml of water

    Dietary Supplement: Water

Interventions

  • Dietary supplementSports drink

    Drink that will be ingested

  • Dietary supplementWater

    Drink that will be ingested

06

What researchers measure

Primary outcomes

  1. Gastric emptying half time

    The time in minutes that half of the volume of the stomach has emptied

    Time frame: 60 minutes

Secondary outcomes

  1. Hunger

    The amount of hunger that the subject feels measured on a visual analogue 10-centimeter line, with the left (0 cm) being labeled 'No Hunger' and the right (10 cm) being labeled 'Maximum hunger'

    Time frame: 60 minutes

07

Study locations

1 of 1 sites recruiting
  • Beth Isreal Deaconess Medical Center
    Boston, Massachusetts 02215, United States
    Recruiting
    • Diana Cepeda · Contactdcepeda@bidmc.harvard.edu · 6176674113
    • Yunping Li, MD · Sub investigator
    • Kowalczyk John, MD · Sub investigator
    • Sween Lindsay, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2021 (actual). Primary completion is estimated for Dec 2027, 82 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 10, 2020
First posted
Jan 14, 2020
StartActual
Feb 1, 2021
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and oversight details
1 update, last Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Minor edits only
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04229043
Responsible party
Phillip Hess (Principal Investigator, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Jan 14, 2020
Start date
Feb 1, 2021
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion